-
Federal
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins
U.S. Department of Health & Human Services —
An explanation for the higher incidence of cardiovascular disease and heart failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial... -
Federal
Implications of recent hypertension trials for the generalist physician: whom do we treat, and how?
U.S. Department of Health & Human Services —
The publication of the results of the Swedish Trial in Old Patients with Hypertension-2 (STOP-2) and the termination of the doxazocin arm of the Antihypertensive and... -
Federal
Debate: The slippery slope of surrogate outcomes
U.S. Department of Health & Human Services —
Surrogate outcomes are frequently used in cardiovascular disease research. A concern is that changes in surrogate markers may not reflect changes in disease outcomes.... -
Federal
Debate: does it matter how you lower blood pressure?
U.S. Department of Health & Human Services —
The evidence base for drug treatment of hypertension is strong. Early trials using thiazide diuretics suggested a shortfall in prevention of coronary heart disease....